St Germain D J CO Inc Gilead Sciences, Inc. Transaction History

St Germain D J CO Inc

$2.12 Billion
Q3 2024

A detailed history of St Germain D J CO Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, St Germain D J CO Inc holds 3,586 shares of GILD stock, worth $327,581. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,586

Previous 3,586 -0.0%

Holding current value

$327,581

Previous $246,000 21.95%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 02, 2024	SELL	$71.58 - $87.29 $8,804 - $10,736	-123 Reduced 3.32%	3,586 $262,000
Q4 2023 Jan 02, 2024	SELL	$73.27 - $83.09 $16,852 - $19,110	-230 Reduced 5.84%	3,709 $300,000
Q2 2023 Sep 07, 2023	SELL	$76.01 - $86.7 $23,335 - $26,616	-307 Reduced 7.23%	3,939 $303,000
Q4 2022 Feb 27, 2023	BUY	$62.32 - $89.47 $34,899 - $50,103	560 Added 15.19%	4,246 $364,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $13,784 - $17,274	-238 Reduced 6.07%	3,686 $219,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $28,676 - $32,548	-442 Reduced 10.12%	3,924 $284,000
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $11,845 - $12,780	-175 Reduced 3.85%	4,366 $305,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $32,340 - $36,899	-539 Reduced 10.61%	4,541 $293,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $250,846 - $285,827	-4,428 Reduced 46.57%	5,080 $296,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $4,657 - $5,856	-75 Reduced 0.78%	9,508 $601,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $4,702 - $5,460	-65 Reduced 0.67%	9,583 $737,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $117,493 - $150,492	-1,876 Reduced 16.28%	9,648 $721,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $404,720 - $445,179	6,568 Added 132.53%	11,524 $749,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $19,378 - $21,390	-310 Reduced 5.89%	4,956 $314,000
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $46,402 - $52,035	-750 Reduced 12.47%	5,266 $356,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $50,711 - $56,810	-811 Reduced 11.88%	6,016 $391,000
Q4 2018 Feb 05, 2019	BUY	$60.54 - $79.0 $64,172 - $83,740	1,060 Added 18.38%	6,827 $427,000
Q3 2018 Oct 23, 2018	BUY	$71.28 - $78.92 $133,008 - $147,264	1,866 Added 47.83%	5,767 $445,000
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $26,146 - $30,499	403 Added 11.52%	3,901 $276,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $35,219 - $41,342	-495 Reduced 12.4%	3,498 $251,000
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $287,935 - $341,281	3,993	3,993 $324,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.

Account

St Germain D J CO Inc Gilead Sciences, Inc. Transaction History